Financials
Financial year 2025
VIRCO PHARMA from Hoeilaart, company number BE0660706392, closed financial year 2025 with a result of € 109,402 after tax. For that financial year VIRCO PHARMA recorded a gross margin of € 477,802 and equity of € 518,933. Compared with financial year 2024, the result moved from € 43,455 to € 109,402. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 6, 2026.
€ 518,933
▲ 27% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 109,402
▲ 152% vs 2024
Profit after tax over the fiscal year.
€ 210,437
▲ 30% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 463,933.
People and assets in 2025
1.3
▼ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 125,339
▼ 2% vs 2024
€ 96,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 52,063
▼ 32% vs 2024
Of which on lease € 46,367.
Debts at end 2025
€ 808,899
▼ 16% vs 2024
€ 119,494 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 290,203
▼ 52% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 112,149
▲ 22% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 357,076 | € 289,651 | € 344,849 | € 477,802 | ▲ 39% |
| Profit after taxes | € 121,185 | € 65,137 | € 43,455 | € 109,402 | ▲ 152% |
| Equity | € 300,939 | € 366,076 | € 409,532 | € 518,933 | ▲ 27% |
| Total debts | € 1,066,558 | € 1,190,669 | € 1,838,278 | € 1,397,188 | ▼ 24% |
| Cash | € 118,971 | € 140,669 | € 162,201 | € 210,437 | ▲ 30% |
| Land & buildings | € 452,035 | € 551,459 | € 880,490 | € 843,487 | ▼ 4% |
| Retained profit | € 245,939 | € 311,076 | € 354,532 | € 463,933 | ▲ 31% |
| Bank debt | € 730,947 | € 740,048 | € 967,012 | € 808,899 | ▼ 16% |
| Balance sheet total | € 1,367,497 | € 1,556,745 | € 2,247,809 | € 1,916,122 | ▼ 15% |
| Employees (FTE) | 0.6 | 0.9 | 1.6 | 1.3 | ▼ 0.3 |
Key figures of VIRCO PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to VIRCO PHARMA?
What happened at VIRCO PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 109,402 (▲ 152% vs 2024). filed late Source: NBB ↗
- New establishment in Hoeilaart. KBO
- Start of the company according to the CBE. KBO
In short
From € 121,185 profit in 2022 to € 109,402 profit in 2025.
Paid € 167,263 in corporate taxes since 2022.
Best year ever: 2022, with € 121,185 profit.
On average € 367,500 of value added per employee in 2025.
Management
Behind VIRCO PHARMA is Virginie Stroobants. Virginie Stroobants is also behind MANIVITH.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Kasteelstraat 1A
1560 Hoeilaart
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0660.706.392
- VAT number
- BE 0660.706.392
- Registered office
- Kasteelstraat 1A, 1560 Hoeilaart
- Names & denominations
- VIRCO PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 August 2016
- Peppol
- Active · Active since 27 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten